Overview
Morphine is often called ‘God’s own medicine’ because it relieves intense pain. Isolated in 1805, it became widely used after the syringe was invented. While injectable morphine caused high addiction, the oral tablet is safer and cheaper.
Key Developments
- 2001: The Union Health Ministry relaxed rules, allowing a single State Drug Control Office to approve RMI status for tablet morphine. Kerala and Tamil Nadu led the change.
- 2014‑2015: Amendments created the category of ENDs. Only the State Drug Controller now needs to approve RMIs for ENDs.
- 2021‑2026: Most Indian states have adopted the tablet form, making it widely available and inexpensive.
Important Facts
- After the NDPS Act of 1985, morphine consumption fell 92 % in 13 years, leaving India with the lowest global usage.
- Oral tablets provide about one‑third the potency of injectables but can be titrated without a dose ceiling until pain is controlled.
- Side‑effects such as constipation and nausea are easily managed with standard medicines.
- The WHO Step‑Ladder of 1986 still guides pain management.
Exam Relevance
The morphine story touches several GS papers. It illustrates health policy formulation (GS3), the role of legislative reforms under the NDPS Act (GS2), and the ethical imperative of palliative care (GS4: Ethics). Understanding how palliative care integrates with public health helps answer questions on disease burden and health‑system strengthening.
Way Forward
- Increase awareness among doctors about the low addiction risk of oral Morphine tablets.
- Streamline the RMI licensing process to a single‑window system at the state level.
- Conduct regular training on ENDs handling and palliative‑care protocols.
- Monitor consumption data to ensure adequate supply without fostering misuse.